» Articles » PMID: 37686434

MTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Sep 9
PMID 37686434
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanistic/mammalian target of rapamycin (mTOR), a member of the phosphoinositide 3-kinase (PI3K) related kinase family, integrates intracellular and environmental cues that coordinate a diverse set of cellular/tissue functions, such as cell growth, proliferation, metabolism, autophagy, apoptosis, longevity, protein/lipid/nucleotide synthesis, and tissue regeneration and repair [...].

Citing Articles

Left ventricular hypertrophy in young hypertensives: the possible crosstalk of mTOR and angiotensin-II -a case-control study.

Oguntola B, Oguntola S, Ojo O, Ukpabio P, Omoaghe A, Olaniyi K BMC Cardiovasc Disord. 2025; 25(1):9.

PMID: 39780084 PMC: 11714912. DOI: 10.1186/s12872-025-04470-9.


Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.

Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.

PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.


Small Extracellular Vesicles Isolated from Cardiac Tissue Matrix or Plasma Display Distinct Aging-Related Changes in Cargo Contributing to Chronic Cardiovascular Disease.

Ronan G, Yang J, Zorlutuna P bioRxiv. 2024; .

PMID: 39713371 PMC: 11661072. DOI: 10.1101/2024.12.06.627231.


Differential expression of cardiometabolic and inflammation markers and signaling pathways between overweight/obese Qatari adults with high and low plasma salivary α-amylase activity.

Khalifa O, Al-Akl N, Arredouani A Front Endocrinol (Lausanne). 2024; 15:1421358.

PMID: 39411310 PMC: 11473332. DOI: 10.3389/fendo.2024.1421358.


Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy.

Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G Signal Transduct Target Ther. 2024; 9(1):262.

PMID: 39353925 PMC: 11445387. DOI: 10.1038/s41392-024-01951-9.


References
1.
Das A, Salloum F, Filippone S, Durrant D, Rokosh G, Bolli R . Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling. Basic Res Cardiol. 2015; 110(3):31. PMC: 8554777. DOI: 10.1007/s00395-015-0486-5. View

2.
Byrne R, Kufner S, Tiroch K, Massberg S, Laugwitz K, Birkmeier A . Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. Heart. 2009; 95(18):1489-94. DOI: 10.1136/hrt.2009.172379. View

3.
Shu Y, Li W, Huang M, Quan Y, Scheffer D, Tian C . Renewed proliferation in adult mouse cochlea and regeneration of hair cells. Nat Commun. 2019; 10(1):5530. PMC: 6892913. DOI: 10.1038/s41467-019-13157-7. View

4.
Woodcock H, Eley J, Guillotin D, Plate M, Nanthakumar C, Martufi M . The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2019; 10(1):6. PMC: 6315032. DOI: 10.1038/s41467-018-07858-8. View

5.
Zhai P, Sciarretta S, Galeotti J, Volpe M, Sadoshima J . Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion. Circ Res. 2011; 109(5):502-11. PMC: 3158807. DOI: 10.1161/CIRCRESAHA.111.249532. View